Smoking cessation and the effect of nicotine dependence on relapse rate in İzmir, Turkey

dc.contributor.authorPekel Ö.
dc.contributor.authorErgör G.
dc.contributor.authorGünay T.
dc.contributor.authorBaydur H.
dc.contributor.authorChoussein B.
dc.contributor.authorBudak R.
dc.contributor.authorDoğanay S.
dc.date.accessioned2024-07-22T08:13:22Z
dc.date.available2024-07-22T08:13:22Z
dc.date.issued2015
dc.description.abstractBackground/aim: Smoking is the leading preventable cause of death in the world. There is growing evidence of the need for communitybased programs on smoking cessation. The main purpose of this study is to establish the rate of smoking cessation and restarting in 1 year at the Balçova Smoking Cessation Center. Materials and methods: This is a prospective study with a study group of 359 individuals who quit smoking at the Balçova Smoking Cessation Center for at least 4 weeks between October 2009 and April 2010. The outcomes of the study were 1-year cessation rate and relapse rate. Individuals who reported restarting and/or had CO measurements above 6 ppm were accepted as quitters who had relapsed. Results: The 1-year rate of smoking cessation was 30.1% for the study group. Of the subjects who quit smoking, 50.1% started smoking again during the 1-year follow-up. Relapse rate was also higher in nicotine addicts. Pharmacological treatment was associated with increased success rates in smoking cessation. Conclusion: Nicotine dependency was shown to be associated with lower rates of smoking cessation and higher rates of relapse. Therefore, it is important to begin smoking cessation attempts before individuals become serious addicts. © TÜBİTAK.
dc.identifier.DOI-ID10.3906/sag-1408-55
dc.identifier.issn13000144
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16327
dc.language.isoEnglish
dc.publisherTurkiye Klinikleri
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectAdult
dc.subjectBehavior Therapy
dc.subjectBenzazepines
dc.subjectBupropion
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNicotinic Agonists
dc.subjectProspective Studies
dc.subjectQuinoxalines
dc.subjectRecurrence
dc.subjectSecondary Prevention
dc.subjectSmoking
dc.subjectSmoking Cessation
dc.subjectTobacco Use Cessation Products
dc.subjectTobacco Use Disorder
dc.subjectTurkey
dc.subjectamfebutamone
dc.subjectnicotine
dc.subjectvarenicline
dc.subjectbenzazepine derivative
dc.subjectnicotine gum
dc.subjectnicotinic agent
dc.subjectquinoxaline derivative
dc.subjectvarenicline
dc.subjectadult
dc.subjectArticle
dc.subjectbehavior therapy
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectinterview
dc.subjectmale
dc.subjectnicotine replacement therapy
dc.subjectoutcome variable
dc.subjectprospective study
dc.subjectrecurrence risk
dc.subjectrelapse
dc.subjectrisk
dc.subjectsmoking cessation
dc.subjecttobacco dependence
dc.subjectTurkey (republic)
dc.subjectadverse effects
dc.subjectbehavior therapy
dc.subjectmiddle aged
dc.subjectprevention and control
dc.subjectprocedures
dc.subjectrecurrent disease
dc.subjectsecondary prevention
dc.subjectsmoking
dc.subjectsmoking cessation
dc.subjectstatistics and numerical data
dc.subjectTobacco Use Disorder
dc.subjectTurkey
dc.titleSmoking cessation and the effect of nicotine dependence on relapse rate in İzmir, Turkey
dc.typeArticle

Files